Send Inquiry

Request To Call Back

Ferric Hydroxide Polymaltose Complex

Get a Price/Quote

Ferric Hydroxide Polymaltose Complex Specification

HS Code
30049099

Taste
Slightly sweet

Color
Brown

Ph Level
5.08.0 (1% solution)

Poisonous
Non-poisonous at therapeutic doses

EINECS No
--

Molecular Formula
[C17H32O16Fe(OH)3]n

Storage
Store in a cool, dry place, protected from light and moisture

Molecular Weight
Varies (approx. 289.03 g/mol per repeating unit)

Structural Formula
Complex polymeric structure: Ferric hydroxide core surrounded by polymaltose chains

Particle Size
Microfine powder, typically <100 microns

Melting Point
Decomposes

Solubility
Soluble in water; forms colloidal solution

Shelf Life
36 months

Smell
Odorless

Heavy Metal (%)
0.002%

Loss on Drying
8.0%

Medicine Name
Ferric Hydroxide Polymaltose Complex

Chemical Name
Ferric Hydroxide Polymaltose Complex

CAS No
9007-72-1

Type
Pharmaceutical Raw Material

Grade
Medicine Grade

Usage
Active Pharmaceutical Ingredient (API); used in the treatment of iron deficiency anemia

Purity(%)
>98%

Appearance
Brown Amorphous Powder

Physical Form
Solid

Therapeutic Area
Hematology

Stability
Stable under recommended storage conditions

pH of 10% solution
5.0-8.0

Quality Standards
Complies with international pharmacopoeial standards (as available)

Microbial Limits
Total bacterial count 1000 CFU/g; Absence of E. coli & Salmonella

Packaging Type
HDPE drums or fiber drums with double polyethylene liner

About Ferric Hydroxide Polymaltose Complex

Ferric Hydroxide polymaltose complex.
This is once again a strong member of our haematinic product range. It supplies iron in ferric form complexed with polymaltose. This is a non ionic molecule and charge of iron is completely shielded. This ensures maximum absorption in the body.

The speciality of this product is iron is completely hydrolysed and thus it remains completely soluble in stomach pH or one can state that the product gives clear blood red solution without turbidity in .1 N HCl solution. The complex is made in such a way that the polymaltose content remains at its highest level. This ensures excellent stability and high absorption of iron .

our product is reddish brown to dark brown amorphous powder and can be comfortably used for liquid,tablets and capsules formulations.

Superior Stability and Quality

Complying with international pharmacopoeial standards, Ferric Hydroxide Polymaltose Complex is engineered for long-term stability, with a 36-month shelf life when stored appropriately. Its stringent microbial and heavy metal limits ensure product safety for pharmaceutical manufacturers.

Optimized for Hematology Applications

Specially designed for use in hematology, this API addresses iron deficiency anemia efficiently. The microfine powder has a particle size less than 100 microns, ensuring uniform dispersion and rapid bioavailability when incorporated into finished dosage forms.

Secure and Reliable Packaging

To maintain integrity throughout storage and transport, the product is sealed in HDPE or fiber drums lined with double polyethylene. This packaging protects the material from moisture and light, preserving its therapeutic efficacy and quality standards.

FAQs of Ferric Hydroxide Polymaltose Complex:

Q: How should Ferric Hydroxide Polymaltose Complex be stored to maintain its quality?

A: Store the product in a cool, dry place, protected from light and moisture. Proper storage conditions ensure stability and preserve its 36-month shelf life.

Q: What are the main therapeutic uses of Ferric Hydroxide Polymaltose Complex?

A: It is primarily used as an active pharmaceutical ingredient (API) in the treatment of iron deficiency anemia within the field of hematology.

Q: Where is Ferric Hydroxide Polymaltose Complex packaged and supplied from?

A: The product is manufactured, exported, and supplied from India, shipped in secure HDPE or fiber drums with double polyethylene liners for optimal protection.

Q: What measures are taken to ensure the microbial and heavy metal safety of the product?

A: The complex meets stringent microbial limits, with total bacterial counts not exceeding 1000 CFU/g and no detected E. coli or Salmonella. Heavy metal content is kept below 0.002% to meet international standards.

Q: When is Ferric Hydroxide Polymaltose Complex recommended for use in pharmaceutical formulations?

A: It is suitable for inclusion in formulations intended for the management of iron deficiency anemia, as specified by healthcare professionals or pharmaceutical guidelines.

Q: How is Ferric Hydroxide Polymaltose Complex administered in end products?

A: While supplied as an amorphous powder, it is intended for incorporation by manufacturers into solid or liquid dosage forms, where it dissolves readily in water to form a colloidal solution for optimal absorption.

Q: What are the benefits of using this complex over other iron supplements?

A: The polymeric structure allows for high iron content with enhanced stability, reduced gastrointestinal side effects, and greater bioavailability compared to many conventional iron salts.

Tell us about your requirement